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Introduction {#sec005}
============

The evidence linking regular physical activity and improved lung function is growing and appears to suggest stronger associations among current smokers \[[@pone.0222578.ref001], [@pone.0222578.ref002]\]. Reduced systemic inflammation, induced by the anti-inflammatory effects of regular long-term physical activity, has been proposed as one potential biological pathway \[[@pone.0222578.ref003]\], but further research into underlying mechanisms is called for \[[@pone.0222578.ref004]\].

Several studies have reported inverse associations between self-reported physical activity and serum C-reactive protein (CRP) levels \[[@pone.0222578.ref005],[@pone.0222578.ref006]\], a commonly used systemic inflammation marker. Higher CRP levels have also been associated with lower lung function and steeper lung function decline \[[@pone.0222578.ref007], [@pone.0222578.ref008]\]. However, no study has explicitly examined whether regular physical activity leads to higher lung function via an effect on systemic inflammation.

We previously reported that regular vigorous physical activity was positively associated with forced expiratory volume in one second (FEV~1~) and forced vital capacity (FVC) in current smokers participating in the multicentre European Community Respiratory Health Survey (ECRHS) \[[@pone.0222578.ref001]\]. To continue this work, we here sought to explore underlying mechanisms. Specifically, we tested the hypothetical role of C-reactive protein levels on the association of physical activity with FEV~1~ and FVC ([Fig 1](#pone.0222578.g001){ref-type="fig"}). Our results indicate that, despite a plausible hypothesis based on the scientific literature, there is no consistent evidence to suggest that the numerous positive associations observed between physical activity and lung function are influenced by changes in CRP levels.

![How CRP levels may influence the association between physical activity and lung function.](pone.0222578.g001){#pone.0222578.g001}

Materials and methods {#sec006}
=====================

Study population {#sec007}
----------------

Over 18,000 participants were originally recruited into the ECRHS from 30 centers in 14 countries in 1991--1993 (ECRHS I) using population-based registers (population-based arm), with an oversampling of asthmatics (symptomatic arm) \[[@pone.0222578.ref009]\]. Two follow-ups approximately ten years apart have since taken place: ECRHS II in 1999--2003 and ECRHS III in 2010--2014. Extensive lifestyle and health information was collected using questionnaires and during measurements at clinical visits throughout the ECRHS (I-III). The current analysis uses cross-sectional data obtained during the first (ECRHS II) and second (ECRHS III) follow-ups, during which physical activity and spirometry data were collected \[[@pone.0222578.ref010], [@pone.0222578.ref011]\]. The analysis is limited to the eight centers that collected data on CRP levels at ECRHS II (Albacete, Barcelona, Galdakao, Grenoble, Paris, Reykjavik, Tartu and Uppsala) and the three centers that collected data on CRP levels at ECRHS III (Grenoble, Paris and Uppsala). Ethical approval from the appropriate ethics committees was obtained by all centers participating in the ECRHS and written consent was obtained from all participants.

Lung function {#sec008}
-------------

Lung function without bronchodilation was assessed according to American Thoracic Society recommendations at both follow-ups \[[@pone.0222578.ref012]\]. FEV~1~ and FVC in absolute values (mL), repeatable to 150 mL from at least two of a maximum of five correct manoeuvres, were used in this analysis. During the lung function testing, body weight and height were measured by trained research staff.

CRP levels {#sec009}
----------

Circulating CRP was measured in frozen stored serum samples which had been taken at both follow-ups, according to standard protocols. Details of the laboratory techniques used in each country to measure the CRP levels are provided in the Supplementary Material ([S1 Appendix](#pone.0222578.s001){ref-type="supplementary-material"}). The CRP data were log-transformed as it followed a log-normal distribution. Afterward, as the laboratory measurement methods varied across centers, the CRP data were standardized per measurement laboratory prior to conducting the analyses (i.e. z-scores were calculated per laboratory method) to account for any potential heterogeneity. There were more participants with CRP data at the first follow-up (ECRHS II; N = 2347, main population, eight centres) compared to the second follow-up (ECRHS III; N = 671, subsample population, three centres).

Physical activity {#sec010}
-----------------

At ECRHS II, leisure-time vigorous physical activity data were collected using self-completed questionnaires ([www.ecrhs.org/quests.htm](http://www.ecrhs.org/quests.htm)). Participants were asked how often (frequency) and for how many hours per week (duration) they usually exercised so much that they got out of breath or sweaty. The responses for frequency were: every day, 4--6 times a week, 2--3 times a week, once a week, once a month, less than once a month and never. For statistical analyses, we grouped together the first two categories, the next two categories and the last three categories. The responses for duration were: 7 hours or more, about 4--6 hours, about 2--3 hours, about 1 hour, about half an hour and none. For statistical analyses, we grouped together the first two categories, the next two categories and the last two categories. Furthermore, as previously done in the ECRHS cohort \[[@pone.0222578.ref001],[@pone.0222578.ref008]\], individuals were classified as physically active if they exercised with a frequency of at least two times per week and for a duration of at least one hour a week, and non-active otherwise.

In the subsample assessed ten years later (ECRHS III), more detailed physical activity measures were collected using the self-completed International Physical Activity Questionnaire (IPAQ-7 short form). The IPAQ collects information on time spent doing physical activity in the previous week and has been validated previously in multiple international settings and population groups \[[@pone.0222578.ref013]\]. Time spent in vigorous, moderate and walking activities, as well as their sum, was derived and expressed in Metabolic Equivalent of Task (METs)-min per week, following the official IPAQ scoring protocol ([www.ipaq.ki.se](http://www.ipaq.ki.se)). Tertiles of each IPAQ-variable were calculated and used in the analysis.

Statistical analyses {#sec011}
--------------------

To test the role of C-reactive protein levels on the association of physical activity with FEV~1~ and FVC ([Fig 1](#pone.0222578.g001){ref-type="fig"}), we first fit a mediator model, where CRP levels are modelled as a function of physical activity, after adjusting for relevant covariates (sex, age, height, weight, education, occupation, secondhand smoke exposure, smoking habit and a random intercept for center, which are the same as used in our previous analysis \[[@pone.0222578.ref001]\]). Next, we constructed the outcome model, which models lung function (the outcome) as a function of CRP levels (the mediator), including the same covariates as used in the mediator model. We used cross-sectional mixed linear regression to estimate both the mediator and outcome models.

The mediator and outcome models were then incorporated into the "mediation" package in the statistical program "R", which estimates the amount of the association between physical activity and lung function that is occurring through changes in CRP. Specifically, the population average causal mediation effect that is occurring through the mediator (i.e. through changing CRP levels, also referred to as the indirect effect), the population average direct effect (remaining effect that is not occurring through changes in CRP levels) and the total effect (the sum of the indirect and direct effects) are calculated using previously developed algorithms \[[@pone.0222578.ref014]\]. Confidence intervals around these effect estimates are calculated using a quasi-Bayesian Monte Carlo method based on normal approximation, which allowed us to determine whether the estimated effects are statistically significantly different from zero (consistent with no effect). Further details of the statistical procedures have been published \[[@pone.0222578.ref015]\].

Sensitivity analyses included (1) stratifying by smoking (never, former, current), body mass index (\< 25 kg/m^2^; 25--30 kg/m^2^; \> 30 kg/m^2^) and asthma, (2) excluding weight from the models (as it could be considered a mediator itself, rather than a confounder), (3) adjusting for body mass index instead of weight, (4) dichotomizing the CRP data based on the highest quartile (≤ 75^th^ vs \> 75^th^ percentile) as well as excluding the highest 5^th^ percentile of CRP levels to assess the potential influence of outliers, and finally, (5) testing for potential exposure-mediator interactions by inserting an interaction term between CRP levels (as a continuous variable) and the physical activity parameters in the "mediator model".

Finally, we calculated E-values for the indirect, direct and total effects, which are a form of sensitivity analysis which estimates the minimum strength of association that an unmeasured confounder would need to have with both the exposure (physical activity) and the outcome (lung function), conditional on the measured covariates, to explain away any observed associations \[[@pone.0222578.ref016], [@pone.0222578.ref017]\].

Results {#sec012}
=======

Of the 3,640 participants from the eight centers that collected CRP data at ECHRS II, 2,347 had the required lung function, physical activity (i.e. activity status) and CRP information for analysis (main study population). Compared to participants from the eight centers that collected CRP information at ECRHS II but who but did not have the required data for analysis (N = 1,293, characteristics described in Table A in [S1 Appendix](#pone.0222578.s001){ref-type="supplementary-material"}), the 2,347 who were included were more likely to be male, older, have asthma and be in a management or technical profession.

Of the 1,097 participants from the three centers that collected CRP data at ECRHS III, 671 of those had the necessary information for analysis, including physical activity data derived using the IPAQ questionnaire (subsample). Compared to participants from the three centers that collected CRP information at ECRHS III but who but did not have the required data for analysis (N = 426, characteristics described in Table A in [S1 Appendix](#pone.0222578.s001){ref-type="supplementary-material"}), the 671 who were included were more likely to be in a management or technical profession.

The main (N = 2,347) and subsample (N = 671) study population characteristics are presented in [Table 1](#pone.0222578.t001){ref-type="table"}. A flow chart depicting the overall derivation of the main study population and subsample is provided in Fig A in [S1 Appendix](#pone.0222578.s001){ref-type="supplementary-material"}.

10.1371/journal.pone.0222578.t001

###### Characteristics of the study population.
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  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristic                                                          Main study population\               Subsample with IPAQ data\                       
                                                                          (ECRHS II, N = 2,347)                (ECRHS III, N = 671)                            
  ----------------------------------------------------------------------- ------------------------------------ --------------------------- --------- --------- --------
  Male sex                                                                                                     1157/2347                   49.3      333/671   49.6

  Symptomatic study arm of ECRHS cohort                                   422/2347                             18.0                        82/671    12.2      

  Age completed full time education                                       \< 17 years                          504/2334                    21.6      43/670    6.4

  17--20 years                                                            732/2334                             31.4                        213/670   31.8      

  \> 20 years                                                             1098/2334                            47.0                        414/670   61.8      

  Age in years[^a^](#t001fn002){ref-type="table-fn"}                                                           42.7                        (7.4)     55.3      (7.1)

  Height in cm[^a^](#t001fn002){ref-type="table-fn"}                                                           170.1                       (9.8)     170.2     (9.7)

  Weight in kg[^a^](#t001fn002){ref-type="table-fn"}                                                           74.0                        (15.1)    76.2      (15.6)

  BMI                                                                     \< 25 kg/m^2^                        1188/2344                   50.7      304/669   45.4

  25--30 kg/m^2^                                                          842/2344                             35.9                        244/669   36.5      

  \> 30 kg/m^2^                                                           314/2344                             13.4                        121/669   18.1      

  Smoking habit                                                           Never                                1000/2347                   42.6      315/671   46.9

  Ex-smoker, \< 15 pack-years                                             357/2347                             15.2                        140/671   20.9      

  Ex-smoker, \> = 15 pack-years                                           254/2347                             10.8                        118/671   17.6      

  Current smoker, \< 15 pack-years                                        279/2347                             11.9                        30/671    4.5       

  Current smoker, \> = 15 pack-years                                      457/2347                             19.5                        68/671    10.1      

  Secondhand smoke exposure at home or work                               1000/2334                            42.8                        107/671   15.9      

  Occupation                                                              Management/professional/non-manual   754/2347                    32.1      338/671   50.4

  Technical/professional/non-manual                                       395/2347                             16.8                        155/671   23.1      

  Other non-manual                                                        549/2347                             23.4                        86/671    12.8      

  Skilled manual                                                          267/2347                             11.4                        29/671    4.3       

  Semi-skilled/unskilled manual                                           240/2347                             10.2                        32/671    4.8       

  Other/unknown                                                           142/2347                             6.1                         31/671    4.6       

  Asthma                                                                                                       412/2343                    17.6      145/670   21.6

  Pre-bronchodilator FEV~1~ in ml[^a^](#t001fn002){ref-type="table-fn"}   3455.2                               (810.1)                     2986.5    (748.8)   

  Pre-bronchodilator FVC in ml[^a^](#t001fn002){ref-type="table-fn"}      4320.7                               (992.4)                     4000.6    (977.8)   

  Physically active                                                       ≥ 2 times and ≥ 1 hr per week        856/2344                    36.5      \--       \--

  Physical activity frequency                                             Low (\< 1 a month)                   976/2347                    41.6      \--       \--

  Medium (1--3 times a week)                                              1016/2347                            43.3                        \--       \--       

  High (\> 4 times a week)                                                355/2347                             15.1                        \--       \--       

  Physical activity duration                                              Low (\< 30 minutes)                  1013/2344                   43.2      \--       \--

  Medium (1--3 hours)                                                     922/2344                             39.3                        \--       \--       

  High (\> 4 hours)                                                       409/2344                             17.4                        \--       \--       

  Total physical activity (MET·min/week)                                  First tertile                        \--                         \--       193/611   31.6

  Second tertile                                                          \--                                  \--                         228/611   37.3      

  Third tertile                                                           \--                                  \--                         190/611   31.1      

  Vigorous physical activity (MET·min/week)                               First tertile                        \--                         \--       320/665   48.1

  Second tertile                                                          \--                                  \--                         117/665   17.6      

  Third tertile                                                           \--                                  \--                         228/665   34.3      

  Moderate physical activity (MET·min/week)                               First tertile                        \--                         \--       223/646   34.5

  Second tertile                                                          \--                                  \--                         178/646   27.6      

  Third tertile                                                           \--                                  \--                         245/646   37.9      

  Walking physical activity (MET·min/week)                                First tertile                        \--                         \--       224/633   35.4

  Second tertile                                                          \--                                  \--                         190/633   30.0      

  Third tertile                                                           \--                                  \--                         219/633   34.6      
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------

BMI = body mass index; ECHRS = European Community Respiratory Health Survey; FEV~1~ = forced expiratory volume in one second; FVC = forced vital capacity; IPAQ = International Physical Activity Questionnaire; MET = Metabolic Equivalent of Task; n = number of participants with characteristic; N = total number of participants available; SD = standard deviation

^a^ The arithmetic mean and standard deviation are presented for these data which were normally distributed

There was little indication of a cross-sectional association between the physical activity parameters and continuous CRP levels (Table B in [S1 Appendix](#pone.0222578.s001){ref-type="supplementary-material"}). CRP was cross-sectionally associated with FEV~1~ and FVC in the main population at ECRHS II (-112.3 ml \[-134.2, -90.4\] and -104.3 ml \[-129.4, -79.2\] per 1 standard deviation increase in log CRP, respectively) and in the subsample at ECRHS III (-87.4 ml \[-127.6, -47.2\] and -76.1 ml \[-122.7, -28.5\] per 1 standard deviation increase in log CRP, respectively).

Despite positive significant associations between nearly all physical activity metrics with FEV~1~ and FVC, there was no consistent evidence for a role of CRP in this association in the entire main study population or when restricted to current smokers ([Table 2](#pone.0222578.t002){ref-type="table"}).

10.1371/journal.pone.0222578.t002

###### Mean difference \[95% confidence intervals\] in lung function (ml) per increase in self-reported physical activity in the main study population at ECRHS II (N = 2347), when restricted to current smokers (N = 736), and when weight is removed from the models.
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  Physical activity      Effect                 Main models[^a^](#t002fn002){ref-type="table-fn"}   Current smokers [^b^](#t002fn003){ref-type="table-fn"}   Weight removed[^c^](#t002fn004){ref-type="table-fn"}                                                 
  ---------------------- ---------------------- --------------------------------------------------- -------------------------------------------------------- ------------------------------------------------------ ---------------------- ---------------------- ----------------------
  Active                                                                                                                                                                                                                                                          
    Yes vs. no           Indirect (via CRP)     -1.2 \[-10.2, 7.4\]                                 -1.7 \[-10.3, 6.4\]                                      9.0 \[-12.7, 29.2\]                                    5.7 \[-14.5, 24.3\]    -1.0 \[-10.5, 8.3\]    -1.2 \[-11.4, 8.7\]
  Direct (not via CRP)   50.8 \[4.9, 90.0\]     60.3 \[8.6, 105.3\]                                 144.3 \[71.7, 224.2\]                                    148.7 \[65.2, 240.3\]                                  51.3 \[7.8, 95.0\]     61.8 \[12.4, 111.6\]   
  Total                  49.5 \[1.6, 91.4\]     58.5 \[4.4, 106.1\]                                 153.3 \[75.4, 238.9\]                                    154.4 \[68.0, 248.9\]                                  50.3 \[7.0, 95.6\]     60.6 \[10.6, 111.4\]   
  Frequency                                                                                                                                                                                                                                                       
   Medium vs. low        Indirect (via CRP)     -1.0 \[-11.0, 8.3\]                                 -2.7 \[-12.3, 6.0\]                                      3.8 \[-16.9, 26.4\]                                    1.3 \[-17.7, 22.1\]    2.4 \[-7.5, 12.3\]     1.1 \[-9.6, 11.6\]
  Direct (not via CRP)   19.0 \[-27.4, 65.5\]   37.3 \[-14.6, 89.3\]                                86.6 \[9.2, 168.0\]                                      113.6 \[26.4, 205.5\]                                  20.1 \[-26.9, 61.7\]   41.2 \[-12.3, 89.0\]   
  Total                  18.0 \[-28.6, 65.4\]   34.6 \[-17.9, 87.6\]                                90.4 \[11.1, 173.5\]                                     114.9 \[25.2, 207.0\]                                  22.5 \[-26.0, 66.5\]   42.2 \[-12.8, 92.2\]   
   High vs. low          Indirect (via CRP)     -3.6 \[-17.0, 9.4\]                                 -4.3 \[-17.1, 8.0\]                                      0.5 \[-29.0, 33.9\]                                    -2.9 \[-30.8, 27.3\]   -7.1 \[-20.9, 6.9\]    -7.9 \[-22.8, 7.1\]
  Direct (not via CRP)   63.3 \[1.1, 124.2\]    71.0 \[-0.5, 139.1\]                                126.9 \[15.8, 241.5\]                                    92.3 \[-36.2, 225.5\]                                  65.5 \[4.1, 126.4\]    71.9 \[2.4, 141.5\]    
  Total                  59.7 \[-4.5, 120.5\]   66.7 \[-4.9, 135.5\]                                127.4 \[13.6, 245.2\]                                    89.4 \[-38.2, 225.4\]                                  58.4 \[-3.8, 121.0\]   64.0 \[-6.7, 135.2\]   
  Duration                                                                                                                                                                                                                                                        
   Medium vs. low        Indirect (via CRP)     -2.3 \[-12.5, 7.5\]                                 -2.5 \[-12.3, 6.6\]                                      6.8 \[-14.1, 29.8\]                                    4.6 \[-14.2, 26.0\]    -0.5 \[-10.6, 9.6\]    -0.4 \[-11.1, 10.5\]
  Direct (not via CRP)   41.6 \[-5.1, 89.3\]    51.3 \[-2.2, 105.8\]                                152.4 \[73.1, 233.1\]                                    165.2 \[75.8, 258.4\]                                  42.5 \[-3.7, 85.6\]    53.9 \[1.4, 103.1\]    
  Total                  39.3 \[-7.5, 87.2\]    48.9 \[-4.7, 103.3\]                                159.2 \[80.4, 240.6\]                                    169.9 \[79.9, 261.5\]                                  42.0 \[-7.0, 85.7\]    53.5 \[-1.8, 102.9\]   
   High vs. low          Indirect (via CRP)     -4.4 \[-17.2, 7.9\]                                 -3.8 \[-15.7, 7.7\]                                      -0.6 \[-29.1, 31.6\]                                   -3.9 \[-30.0, 25.0\]   -4.7 \[-17.9, 8.3\]    -4.5 \[-18.7, 9.0\]
  Direct (not via CRP)   61.2 \[2.8, 118.7\]    70.2 \[3.8, 136.0\]                                 142.6 \[35.1, 254.8\]                                    94.7 \[-26.9, 221.6\]                                  63.1 \[5.6, 120.0\]    73.3 \[8.7, 138.0\]    
  Total                  56.8 \[-2.2, 113.7\]   66.4 \[1.0, 130.2\]                                 141.9 \[32.4, 254.1\]                                    90.8 \[-31.1, 220.9\]                                  58.4 \[0.9, 117.0\]    68.8 \[3.7, 135.1\]    

CRP = C-reactive protein; ECHRS = European Community Respiratory Health Survey; FEV~1~ = forced expiratory volume in one second; FVC = forced vital capacity

^a^ Models are adjusted for sex, age, height, weight, education, occupation, secondhand smoke exposure, smoking habit and include a random intercept for center.

^b^ Models are adjusted for sex, age, height, weight, education, occupation, secondhand smoke exposure and include a random intercept for center.

^c^ Models are adjusted for sex, age, height, education, occupation, secondhand smoke exposure, smoking habit and include a random intercept for center.

When using the IPAQ-physical activity variables available in the subsample assessed ten years later, a role of CRP on the association between physical activity levels and lung function was only apparent when comparing the second to first tertiles of METs in moderate activity (mean difference and 95% confidence intervals of 21.1 \[5.2, 41.9\] ml and 17.3 \[2.6, 38.0\] ml for FEV~1~ and FVC, respectively, [Table 3](#pone.0222578.t003){ref-type="table"}).

10.1371/journal.pone.0222578.t003

###### Mean difference \[95% confidence intervals\] in lung function (ml) per increase in self-reported physical activity in the subsample with IPAQ data at ECRHS III (N = 671), when restricted to current smokers (N = 98), and when weight is removed from the models.
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  Physical activity (IPAQ)   Effect                  Main models[^a^](#t003fn002){ref-type="table-fn"}   Current smokers [^b^](#t003fn003){ref-type="table-fn"}   Weight removed[^c^](#t003fn004){ref-type="table-fn"}                                                     
  -------------------------- ----------------------- --------------------------------------------------- -------------------------------------------------------- ------------------------------------------------------ ------------------------ ------------------------ ----------------------
  Total                                                                                                                                                                                                                                                                    
   T2 vs T1                  Indirect (via CRP)      9.7 \[-6.3, 27.9\]                                  7.0 \[-6.1, 23.4\]                                       -22.0 \[-93.8, 24.0\]                                  -30.2 \[-118.5, 33.7\]   14.5 \[-2.2, 34.3\]      13.6 \[-3.7, 34.6\]
  Direct (not via CRP)       15.1 \[-73.5, 108.7\]   90.1 \[-14.7, 201\]                                 172.6 \[-84.5, 453.2\]                                   254.8 \[-32.8, 519.4\]                                 15.7 \[-73.5, 108.6\]    93.1 \[-11.8, 203.1\]    
  Total                      24.9 \[-69.0, 120.4\]   97.1 \[-9.8, 209.1\]                                150.7 \[-92.3, 426.8\]                                   224.6 \[-77.6, 486.4\]                                 30.2 \[-57.3, 122.5\]    106.7 \[2.4, 215.5\]     
   T3 vs T1                  Indirect (via CRP)      7.0 \[-9.8, 25.8\]                                  7.0 \[-6.9, 24.6\]                                       -11.9 \[-78.1, 31.8\]                                  -20.9 \[-120.2, 47.7\]   14.3 \[-4.3, 33.8\]      16.3 \[-3.0, 38.1\]
  Direct (not via CRP)       86.3 \[-15.6, 180.1\]   176.5 \[55.8, 288.1\]                               284.0 \[-10.6, 553.4\]                                   274.7 \[-23.9, 565.9\]                                 91.4 \[2.5, 182.1\]      185.5 \[79.0, 294.9\]    
  Total                      93.3 \[-7.7, 187.7\]    183.5 \[63.7, 296.8\]                               272.0 \[-18.7, 539.7\]                                   253.8 \[-56.5, 563.4\]                                 105.7 \[15.1, 202.5\]    201.8 \[94.3, 316.7\]    
  Vigorous                                                                                                                                                                                                                                                                 
   T2 vs T1                  Indirect (via CRP)      6.4 \[-11.0, 24.1\]                                 6.0 \[-8.6, 23.2\]                                       10.7 \[-36.7, 80.8\]                                   19.9 \[-46.6, 115.8\]    14.6 \[-3.2, 35.5\]      18.4 \[-0.9, 42.2\]
  Direct (not via CRP)       24.7 \[-73.7, 131.3\]   68.3 \[-47.6, 193.0\]                               115.5 \[-237.7, 479.9\]                                  251.0 \[-119.9, 639.1\]                                33.0 \[-66.6, 139.0\]    85.6 \[-31.3, 209.2\]    
  Total                      31.0 \[-71.8, 140.2\]   74.3 \[-44.5, 199.2\]                               126.2 \[-224.2, 491.9\]                                  271.0 \[-97.2, 669.3\]                                 47.6 \[-53.8, 151.9\]    104.0 \[-13.9, 225\]     
   T3 vs T1                  Indirect (via CRP)      10.4 \[-2.6, 26.9\]                                 9.5 \[-1.2, 25.2\]                                       7.8 \[-22.8, 50.0\]                                    15.9 \[-21.3, 69.5\]     17.5 \[1.9, 35.0\]       20.5 \[3.4, 40.5\]
  Direct (not via CRP)       100.7 \[14.9, 180.0\]   140.0 \[38.7, 233.6\]                               210.4 \[-18.0, 425.9\]                                   248.0 \[15.5, 462.0\]                                  102.1 \[26.3, 180.2\]    147.4 \[57.4, 239.4\]    
  Total                      111.1 \[25.6, 191.2\]   149.5 \[48.8, 243.4\]                               218.2 \[-12.2, 429.4\]                                   264.0 \[31.9, 479.3\]                                  119.6 \[42.2, 200.8\]    167.8 \[76.5, 264.8\]    
  Moderate                                                                                                                                                                                                                                                                 
   T2 vs T1                  Indirect (via CRP)      21.1 \[5.2, 41.9\]                                  17.3 \[2.6, 38.0\]                                       9.9 \[-24.2, 62.6\]                                    15.7 \[-45.4, 87.6\]     27.4 \[9.7, 49.7\]       30.6 \[10.7, 56.2\]
  Direct (not via CRP)       60.8 \[-32.7, 161.2\]   82.0 \[-29.3, 199.3\]                               152.9 \[-102.5, 405.6\]                                  195.9 \[-65.8, 450.0\]                                 56.5 \[-34.2, 149.8\]    80.1 \[-27.7, 191.6\]    
  Total                      81.9 \[-13.7, 179.7\]   99.4 \[-11.3, 214.0\]                               162.7 \[-83.7, 424.5\]                                   211.6 \[-65.5, 466.3\]                                 83.9 \[-6.2, 179.4\]     110.7 \[2.3, 223.8\]     
   T3 vs T1                  Indirect (via CRP)      7.9 \[-5.5, 24.1\]                                  6.6 \[-5.1, 21.8\]                                       -12.3 \[-72.0, 20.3\]                                  -21.1 \[-115.1, 35.5\]   14.8 \[-0.8, 32.3\]      16.4 \[-0.8, 36.4\]
  Direct (not via CRP)       68.5 \[-25.3, 152.2\]   155.3 \[43.8, 255.4\]                               57.1 \[-212.2, 314.2\]                                   122.9 \[-151.9, 402.0\]                                67.6 \[-12.2, 150.4\]    159.0 \[64.0, 257.4\]    
  Total                      76.4 \[-16.4, 162.6\]   161.9 \[51.6, 264.6\]                               44.8 \[-225.0, 297.0\]                                   101.8 \[-199.0, 389.5\]                                82.4 \[1.8, 169.7\]      175.4 \[79.5, 277.5\]    
  Walking                                                                                                                                                                                                                                                                  
   T2 vs T1                  Indirect (via CRP)      2.5 \[-14.6, 19.6\]                                 2.2 \[-12.8, 18.4\]                                      3.8 \[-26.5, 47.2\]                                    12.9 \[-38.9, 80.9\]     -2.2 \[-20.8, 16.1\]     -2.7 \[-23.2, 17.2\]
  Direct (not via CRP)       -5.3 \[-97.2, 92.2\]    5.9 \[-101.7, 119.7\]                               263.3 \[-6.8, 536.9\]                                    222.7 \[-51.3, 502.8\]                                 -7.2 \[-97.8, 86.0\]     -2.0 \[-109.3, 109.1\]   
  Total                      -2.8 \[-96.9, 97.8\]    8.1 \[-100.3, 125.2\]                               267.1 \[1.3, 558.2\]                                     235.5 \[-32, 533.3\]                                   -9.4 \[-99.5, 85.4\]     -4.7 \[-111.3, 105.5\]   
   T3 vs T1                  Indirect (via CRP)      -1.4 \[-19.2, 15.8\]                                -2.1 \[-18.7, 13.1\]                                     -18.9 \[-104, 45.5\]                                   -50 \[-161.8, 13.8\]     0.9 \[-18.7, 19.1\]      -1.5 \[-23.2, 18.2\]
  Direct (not via CRP)       -1.1 \[-97.6, 88.1\]    -2.6 \[-115.7, 102.7\]                              52.4 \[-293.8, 363.8\]                                   44.6 \[-308.8, 359.3\]                                 4.1 \[-83.5, 94.1\]      2.8 \[-101.5, 108.7\]    
  Total                      -2.5 \[-97.7, 89.9\]    -4.7 \[-117.5, 103.1\]                              33.4 \[-296.6, 333.3\]                                   -5.4 \[-335.3, 297.6\]                                 5.0 \[-84.3, 100.4\]     1.3 \[-104.4, 114.0\]    

CRP = C-reactive protein; ECHRS = European Community Respiratory Health Survey; FEV~1~ = forced expiratory volume in one second; FVC = forced vital capacity; IPAQ = International Physical Activity Questionnaire; T1 = first tertile; T2 = second tertile; T3 = third tertile

^a^ Models are adjusted for sex, age, height, weight, education, occupation, secondhand smoke exposure, smoking habit and include a random intercept for center.

^b^ Models are adjusted for sex, age, height, weight, education, occupation, secondhand smoke exposure and include a random intercept for center.

^c^ Models are adjusted for sex, age, height, education, occupation, secondhand smoke exposure, smoking habit and include a random intercept for center.

All listed sensitivity analyses conducted yielded similar null findings for a role of CRP, and we found no evidence to suggest the existence of potential mediator-exposure interactions. Only the removal of weight from the model led to one additional significant mediation association when comparing the third to first tertiles of METs in vigorous physical activity in the subsample (17.5 \[1.9, 35.0\] ml for FEV~1~ and 20.5 \[3.4, 40.5\] ml for FVC, [Table 3](#pone.0222578.t003){ref-type="table"}).

E-values for the observed direct effects of physical activity on lung function suggest that an unmeasured confounder that was associated with both physical activity and lung function by a risk ratio of ≥ 1.30 in the main population and \> 1.50 in the subsample population, after adjustment for all observed confounders, could explain away the estimate, but weaker confounding could not. For the single indirect effect observed in the subsample (when comparing the second to first tertiles of METs in moderate activity), weaker risk ratios with an unknown confounder would be required to explain away the estimates (E-values were 1.19 for FEV~1~ and 1.14 for FVC; Table C in [S1 Appendix](#pone.0222578.s001){ref-type="supplementary-material"}).

Discussion {#sec013}
==========

This study found no consistent evidence to suggest that the association of physical activity on lung function occurs through changes in CRP levels. Only in the subsample with more detailed physical activity data was a potential role for CRP identified for moderate physical activity, which may represent a true or chance finding. Removing weight from the models did yield one additional association as evidence for a role of CRP for vigorous physical activity in the subsample, but this result should be interpreted with caution as it is difficult to conclude whether this suggests that weight might lie in the causal pathway or that residual confounding by weight is present.

The current study was motivated by the hypothesis that regular physical activity creates an anti-inflammatory environment in the long-term \[[@pone.0222578.ref003]\], which leads to higher lung function. We chose to use individual-level variations in CRP levels to explore this hypothesis because studies have shown that higher physical activity is associated with lower CRP levels \[[@pone.0222578.ref005],[@pone.0222578.ref006]\] and higher CRP levels are associated with both lower lung function and steeper lung function decline \[[@pone.0222578.ref007],[@pone.0222578.ref008]\]. Despite this existing literature supporting our choice, CRP levels may not be the ideal marker as very high values can be observed. However, our results remained consistent in sensitivity analyses in which the CRP data were dichotomized based on the highest quartile (≤ 75^th^ vs \> 75^th^ percentile) and the highest 5^th^ percentile of CRP levels were excluded.

Given our hypothesis of a role of anti-inflammation, the use of "vigorous physical activity" in the main population may thus not have been optimal, as this type of activity may be partially pro-inflammatory. However, we have previously found this type of activity to be consistently associated with higher lung function \[[@pone.0222578.ref001]\]. In the subsample, we did have more detailed physical activity measures available collected using the IPAQ questionnaire, which allowed more moderate anti-inflammatory types of physical activity to be considered. However, these associations risk being underpowered given the smaller sample size available.

Although we included major confounders in our analyses and tested for potential exposure-mediator interactions, we cannot verify that all assumptions were met regarding residual confounding (e.g. diet data are missing) \[[@pone.0222578.ref018]\]. Furthermore, participants included in this study differed from those for whom some necessary data were missing and this non-random retention may have affected the effect estimates. Notably, individuals in management or technical professions were over-represented in both the main and subsample study populations. Additionally, the directionality of any causal pathway cannot be fully assessed as all associations tested were cross-sectional due to the limited availability of repeated CRP data within centers. However, we found no indication that reverse causation may be responsible for the observed association between physical activity and lung function in a previous longitudinal analysis in the ECRHS \[[@pone.0222578.ref001]\].

Despite the aforementioned limitations, this study is the first to examine whether reduced systemic inflammation underlies the association between increased physical activity and improved lung function using a mediation analysis. The rather null associations observed leads us to suggest that future studies should evaluate other biomarkers of systemic inflammation, such as anti-inflammatory cytokines released from contracting skeletal muscle during exercise, and include more detailed (type and intensity) and repeated data on physical activity. Furthermore, other mechanisms should be explored, such as the potential for physical activity to lead to beneficial changes in body composition and fat distribution and changes in respiratory muscle endurance and strength, both of which may affect lung function. A better understanding of the underlying biological mechanisms is required to strengthen causal inference between physical activity and lung function. It will also provide a gateway for developing informed and effective public health policies.
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